ORGO
Organogenesis Holdings Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$1.71
+4.27%Leverage
- Debt / equity
- 0.23x
- Net debt / equity
- 0.07x
- Debt / assets
- 0.16x
- Debt / EBITDA
- -14.16x
- Net debt / EBITDA
- -4.41x
Liquidity & coverage
- Current ratio
- 3.52x
- Quick ratio
- 3.00x
- Cash ratio
- 0.81x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $143.3M
Cash & dividend
- FCF / debt
- 0.31x
- Cash flow / debt
- 0.48x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026